University of Arizona

University, FunderROROpenAlexWikidata

People

Sources: reporter.nih.gov

Part of

Sources: wikidata.org

Founded

  • Founded

    Jan 1, 1885

Sources: ror.org

Trials

Sources: clinicaltrials.gov

Grants and prizes

  • National Cancer Institute

    U54, 2/2 Partnership for Native American Cancer Prevention, U54CA143924, $1.6M, 2009–2029, Sep 17, 2026

  • National Institute on Aging

    U01, Transforming Alzheimer's Risk Factor Therapeutics into Precision Combination Therapies to Treat AD, U01AG095263, $2.7M, 2026–2031, Sep 10, 2026

  • National Institute on Aging

    R56, Developing small molecule therapeutics for TDP-43 associated neurodegenerative diseases, R56AG097418, $640K, 2026–2027, Sep 9, 2026

  • National Cancer Institute

    R35, Understanding and Exploiting Loss of Y in Cancer, R35CA294022, $924K, 2025–2032, Sep 8, 2026

  • National Cancer Institute

    UG1, University of Arizona Cancer Prevention Clinical Trials Network, UG1CA242596, $851K, 2019–2031, Sep 4, 2026

  • National Institute on Aging

    P01, Perimenopause in Brain Aging and Alzheimer's Disease, P01AG026572, $5.1M, 2006–2031, Sep 3, 2026

  • National Institute of Environmental Health Sciences

    R01, PFAS Exposure, PFAS Mitigation, and ADRD Biomarkers and Cognition, R01ES039490, $763K, 2026–2031, Sep 3, 2026

  • National Institute on Aging

    R56, Plasticity Reserve in Alzheimer's Disease: Longitudinal Insights from Preclinical and Prodromal Stages., R56AG096875, $396K, 2026–2027, Sep 1, 2026

  • National Institute of Neurological Disorders and Stroke

    RF1, Pathological relevance of TDP-43 interactions with translation machinery in neurodegeneration, RF1NS149974, $1.8M, 2026–2029, Aug 31, 2026

  • National Heart, Lung, and Blood Institute

    R01, Duerme Mejor: Promoting Sleep Health at the US-Mexico Border, R01HL183250, $739K, 2026–2031, Aug 28, 2026

  • Mayo Clinic

    Role of p21 positive senescent cells in radiation-induced skeletal injury and repair (sub-award to UNIVERSITY OF ARIZONA), usaspending_subaward/ASST_NON_R01AG082681_075/ED44Y3W6P7B9, $40.9K, 2026, Aug 27, 2026

  • National Institute on Aging

    UG3, PNA5 For Treatment of Vascular Cognitive Impairment and Dementia (VCID) and Alzheimer's disease related dementias (ADRD): A Phase 1a Safety and Tolerability Study, UG3AG104642, $6.3M, 2026–2027, Aug 27, 2026

  • National Cancer Institute

    R00, Cognitive Science to Radiology: Using EEG and Eye-tracking to Determine Why, How, and When Novices and Radiologists Miss Signs of Breast Cancer in Multiple-abnormality Mammography and Tomosynthesis, R00CA267163, $249K, 2022–2027, Aug 26, 2026

  • National Heart, Lung, and Blood Institute

    R01, Early Origins of Chronic Lung Disease: From Birth to Age 45 Years, R01HL132523, $1.8M, 2016–2030, Aug 21, 2026

  • National Heart, Lung, and Blood Institute

    R01, Assessing Clinical Effectiveness and Implementation of Worksite Sleep Health Coaching in Firefighters, R01HL162799, $784K, 2023–2028, Aug 20, 2026

  • National Institute on Aging

    T32, Translational Research in Alzheimer's Disease and related Dementias (TRADD), T32AG082631, $301K, 2023–2028, Aug 18, 2026

  • National Center for Chronic Disease Prev and Health Promo

    Community-Based Participatory Research to Enhance Vaccine Uptake Across the Lifespan through Innovative Points of Access and Altering Norms in Border and Rural Regions, U48DP006882, $390K, Aug 14, 2026

  • National Institute on Aging

    U01, PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: an FDA required Toxicology Study, U01AG082617, $1.9M, 2023–2027, Aug 13, 2026

  • National Heart, Lung, and Blood Institute

    R01, Endothelial-Mediated Genetic Risk for Vascular Disease, R01HL180762, $779K, 2026–2030, Aug 12, 2026

  • National Institute on Aging

    R01, The contribution of declines in functional connectivity to cognitive aging, R01AG049722, $532K, 2016–2027, Aug 6, 2026

Sources: reporter.nih.gov, openalex.org

Grants and prizes awarded

  • University of California at Davis

    Determinants of age-induced hearing loss and reversal strategies (sub-award to UNIVERSITY OF CALIFORNIA, DAVIS), usaspending_subaward/ASST_NON_P01AG051443_075/TX2DAGQPENZ5, $175K, 2025, Nov 14, 2025

  • University of Southern California

    Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial (sub-award to UNIVERSITY OF SOUTHERN CALIFORNIA), usaspending_subaward/ASST_NON_R01AG063826_075/G88KLJR3KYT5, $72.9K, 2025, Jul 22, 2025

  • University of Missouri

    Precision Aging Network: Closing the Gap Between Cognitive Healthspan andHuman Lifespan (sub-award to THE CURATORS OF THE UNIVERSITY OF MISSOURI), usaspending_subaward/ASST_NON_U19AG065169_075/J9CDGR596MN3, $47.9K, 2025, Jun 2, 2025

  • Kaiser Foundation Hospital

    Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and foll (sub-award to KAISER FOUNDATION HOSPITALS), usaspending_subaward/ASST_NON_R01CA265020_075/P1RTMASB37B5, $456K, 2025, May 20, 2025

Sources: openalex.org

Funded papers

Sources: api.crossref.org, openalex.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov

Papers